Cargando…
Hepatokines as a Link between Obesity and Cardiovascular Diseases
Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus. Recent emerging evidence suggests that a group of predominantly liver-derived proteins call...
Autores principales: | Yoo, Hye Jin, Choi, Kyung Mook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342531/ https://www.ncbi.nlm.nih.gov/pubmed/25729707 http://dx.doi.org/10.4093/dmj.2015.39.1.10 |
Ejemplares similares
-
Implication of hepatokines in metabolic disorders and cardiovascular diseases
por: Jung, Tae Woo, et al.
Publicado: (2016) -
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021) -
Hepatokines as a Molecular Transducer of Exercise
por: Seo, Dae Yun, et al.
Publicado: (2021) -
Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines
por: Oh, Kyoung-Jin, et al.
Publicado: (2016) -
Role of Hepatokines in Non-alcoholic Fatty Liver Disease
por: Ke, Yini, et al.
Publicado: (2019)